Bausch Health Companies Inc. (BHC)
USD 7.34
(-4.43%)
USD 7.34
(-4.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 8.75 Billion | 8.12 Billion | 8.43 Billion | 8.02 Billion | 8.6 Billion | 8.38 Billion |
| Cost of Revenue | 2.55 Billion | 2.36 Billion | 2.39 Billion | 2.24 Billion | 2.35 Billion | 2.35 Billion |
| Gross Profit | 6.19 Billion | 5.76 Billion | 6.04 Billion | 5.77 Billion | 6.25 Billion | 6.02 Billion |
| Operating Expenses | 5.23 Billion | 4.4 Billion | 4.83 Billion | 4.46 Billion | 6.33 Billion | 5.53 Billion |
| Selling, General and Administrative Expenses | 2.91 Billion | 2.62 Billion | 2.62 Billion | 2.36 Billion | 2.55 Billion | 2.47 Billion |
| Research and Development Expenses | 604 Million | 529 Million | 465 Million | 452 Million | 471 Million | 414 Million |
| Other Expenses | 1.71 Billion | 1.25 Billion | 1.74 Billion | 1.64 Billion | 3.31 Billion | 21 Million |
| Cost and Expenses | 7.79 Billion | 6.76 Billion | 7.23 Billion | 6.71 Billion | 8.68 Billion | 7.88 Billion |
| Operating Income | 963 Million | 1.37 Billion | 1.21 Billion | 676 Million | -73 Million | -2.38 Billion |
| Interest Expense | 1.32 Billion | 1.46 Billion | 1.42 Billion | 1.53 Billion | 1.61 Billion | 1.68 Billion |
| Income Tax Expense | 221 Million | 83 Million | -87 Million | -375 Million | -54 Million | -10 Million |
| Earnings before Tax | -390 Million | -129 Million | -1.02 Billion | -934 Million | -1.83 Billion | -4.15 Billion |
| Net Income | -592 Million | -212 Million | -937 Million | -559 Million | -1.78 Billion | -4.14 Billion |
| Earnings Per Share Basic | -1.62 | -0.59 | -2.61 | -1.57 | -5.06 | -11.86 |
| Earnings Per Share Diluted | -1.62 | -0.59 | -2.61 | -1.57 | -5.06 | -11.86 |
| Weighted Average Shares Outstanding | 364.9 Million | 362 Million | 358.9 Million | 355 Million | 352.1 Million | 349.87 Million |
| Weighted Average Shares Outstanding (Diluted) | 364.9 Million | 362 Million | 358.9 Million | 355 Million | 352.1 Million | 349.87 Million |
| Gross Margin | 0.71 | 0.71 | 0.72 | 0.72 | 0.73 | 0.72 |
| EBIT Margin | 0.33 | 0.32 | 0.31 | 0.31 | 0.21 | 0.38 |
| Profit Margin | -0.07 | -0.03 | -0.11 | -0.07 | -0.21 | -0.49 |
| EBITDA | 2.88 Billion | 2.62 Billion | 1.93 Billion | 2.55 Billion | 1.89 Billion | 332.15 Million |
| Earnings Before Tax Margin | 0.11 | 0.17 | 0.14 | 0.08 | -0.01 | -0.28 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.51 Billion | 2.4 Billion | 2.14 Billion | 2.4 Billion | 8.75 Billion | 2.23 Billion |
| Cost of Revenue | 14 Million | 988.79 Million | 909.91 Million | -1.81 Billion | 2.55 Billion | 623 Million |
| Gross Profit | 2.49 Billion | 1.41 Billion | 1.23 Billion | 4.22 Billion | 6.19 Billion | 1.61 Billion |
| Operating Expenses | 996 Million | 987.79 Million | 940.77 Million | 918 Million | 4.59 Billion | 1.12 Billion |
| Selling, General and Administrative Expenses | 850 Million | 831.82 Million | 790.45 Million | 766 Million | - | 715 Million |
| Research and Development Expenses | 146 Million | 155.96 Million | 150.32 Million | 152 Million | - | 153 Million |
| Other Expenses | - | -3 Million | - | -234.67 Million | -1 Million | -60 Million |
| Cost and Expenses | 1.01 Billion | 1.97 Billion | 1.85 Billion | -896 Million | 7.15 Billion | 1.74 Billion |
| Operating Income | 318 Million | 425.91 Million | 292.68 Million | 362 Million | 963 Million | 14 Million |
| Interest Expense | -346 Million | 350 Million | 355 Million | -2.29 Billion | 1.32 Billion | 339 Million |
| Income Tax Expense | -71 Million | 48.98 Million | 7.96 Million | -402 Million | 221 Million | 56 Million |
| Earnings before Tax | -21 Million | 47.99 Million | -68.69 Million | -7 Million | -390 Million | -326 Million |
| Net Income | -85 Million | 10 Million | -63.71 Million | 395 Million | -592 Million | -378 Million |
| Earnings Per Share Basic | -0.23 | 0.03 | -0.17 | 1.08 | - | -1.03 |
| Earnings Per Share Diluted | -0.23 | 0.03 | -0.17 | 1.08 | - | -1.03 |
| Weighted Average Shares Outstanding | 368.4 Million | 367.9 Million | 366.8 Million | 365.23 Million | 364.9 Million | 365.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 368.4 Million | 370.2 Million | 366.8 Million | 365.23 Million | 364.9 Million | 365.4 Million |
| Gross Margin | 0.99 | 0.59 | 0.58 | 1.75 | 0.71 | 0.72 |
| EBIT Margin | 0.13 | 0.31 | 0.29 | -1.30 | - | 0.31 |
| Profit Margin | -0.03 | 0.00 | -0.03 | 0.16 | -0.07 | -0.17 |
| EBITDA | 318 Million | 743.84 Million | 611.25 Million | -3.12 Billion | - | 693 Million |
| Earnings Before Tax Margin | 0.13 | 0.18 | 0.14 | 0.15 | 0.11 | 0.01 |
LEGN
600649
HWAL
688788
MEDICAMEQ
3880